(Total Views: 786)
Posted On: 06/06/2020 11:17:19 AM
Post# of 153875
Re: reallypeople? #36876
Off the back of my hand, Nadar said on a CC that in a clinical study for the critically ill in China( like the Montefiore study) 31/32 patients died.
However, I stand corrected. According to this article, it’s @ 31%.
https://www.futurity.org/covid-19-mortality-rate-2377362-2/ Because most S2C patients have permanent damage, I’m pretty sure those getting Leron -since there is improvement from day 3- will clinically be in better shape. In fact, NP was way more excited about this trial than the M2M. He kinda insinuated that people weren’t dying on LERO for this trial or that it at least greatly improved mortality rates. He said something like @the virus isn’t the problem, it’s people dying!” 31% is unacceptable, so from his statements that percentage is much lower. You can tell who died if the lab samples stop coming in.
However, I stand corrected. According to this article, it’s @ 31%.
https://www.futurity.org/covid-19-mortality-rate-2377362-2/ Because most S2C patients have permanent damage, I’m pretty sure those getting Leron -since there is improvement from day 3- will clinically be in better shape. In fact, NP was way more excited about this trial than the M2M. He kinda insinuated that people weren’t dying on LERO for this trial or that it at least greatly improved mortality rates. He said something like @the virus isn’t the problem, it’s people dying!” 31% is unacceptable, so from his statements that percentage is much lower. You can tell who died if the lab samples stop coming in.
(0)
(0)
